Agilent Technologies Inc.
Agilent Technologies Reports Q2 2025 Financial Results and Raises Full-Year Outlook
Summary
Agilent Technologies, Inc. reported financial results for the second fiscal quarter of 2025 on May 28, 2025. The company posted revenue of $1.67 billion, representing a 6.0% increase from the same period in 2024. GAAP net income was $215 million, or $0.75 per share, down from $308 million, or $1.05 per share, in the second quarter of 2024. Non-GAAP net income was $373 million, or $1.31 per share, compared to $356 million, or $1.22 per share, in the year-ago quarter. The company has raised its full-year revenue outlook to a range of $6.73 billion to $6.81 billion, with non-GAAP EPS expected in the range of $5.54 to $5.61.
Profitelligence Alerts
Get alerts for A
Be first to know when Agilent Technologies Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Official SEC Documents
Advertisement